Literature DB >> 18458798

[Future treatment options for chronic wounds].

L Steinsträsser1, R Hasler, T Hirsch, A Daigeler, S Langer, H U Steinau.   

Abstract

The skin plays an important role in the human immune system, working as a barrier to pathologic influences. A chronic wound breaks that barrier and eliminates that function. Affected patients can suffer from significant reductions in quality of life and become socially isolated. The inability to work may have serious economic consequences for the individual and the community. Treating these wounds with novel, evidence-based techniques can accelerate wound healing while reducing the length of in- and outpatient treatment and thereby the overall costs. This article discusses current and future treatment options in wound conditioning, therapy, and regeneration.

Entities:  

Mesh:

Year:  2008        PMID: 18458798     DOI: 10.1007/s00104-008-1504-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.920


  39 in total

1.  Wound healing trajectories as predictors of effectiveness of therapeutic agents.

Authors:  M C Robson; D P Hill; M E Woodske; D L Steed
Journal:  Arch Surg       Date:  2000-07

Review 2.  Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review.

Authors:  Mark L Venturi; Christopher E Attinger; Ali N Mesbahi; Christopher L Hess; Katherine S Graw
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

3.  The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers.

Authors:  Lars Steinstraesser; Andre Ring; Robert Bals; Hans-Ulrich Steinau; Stefan Langer
Journal:  Ann Plast Surg       Date:  2006-01       Impact factor: 1.539

Review 4.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

5.  Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective.

Authors:  A R Berendt
Journal:  Clin Infect Dis       Date:  2006-06-12       Impact factor: 9.079

6.  Direct measurement of wound and tissue oxygen tension in postoperative patients.

Authors:  N Chang; W H Goodson; F Gottrup; T K Hunt
Journal:  Ann Surg       Date:  1983-04       Impact factor: 12.969

7.  The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium.

Authors:  Johan D Heilborn; Margareta Frohm Nilsson; Gunnar Kratz; Günther Weber; Ole Sørensen; Niels Borregaard; Mona Ståhle-Bäckdahl
Journal:  J Invest Dermatol       Date:  2003-03       Impact factor: 8.551

Review 8.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  P Kranke; M Bennett; I Roeckl-Wiedmann; S Debus
Journal:  Cochrane Database Syst Rev       Date:  2004

9.  [Vacuum sealing as treatment of soft tissue damage in open fractures].

Authors:  W Fleischmann; W Strecker; M Bombelli; L Kinzl
Journal:  Unfallchirurg       Date:  1993-09       Impact factor: 1.000

10.  Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.

Authors:  De Yang; Arya Biragyn; David M Hoover; Jacek Lubkowski; Joost J Oppenheim
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  2 in total

1.  Antiseptics in surgery.

Authors:  Tobias Hirsch; Hans-Martin Seipp; Frank Jacobsen; Ole Goertz; Hans-Ulrich Steinau; Lars Steinstraesser
Journal:  Eplasty       Date:  2010-05-27

2.  [A comparative in vitro study of cell toxicity of clinically used antiseptics].

Authors:  T Hirsch; F Jacobsen; A Rittig; O Goertz; A Niederbichler; H U Steinau; H M Seipp; L Steinstraesser
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.